Healthcare - Medical - Devices - NASDAQ - US
$ 6.34
-1.71 %
$ 250 M
Market Cap
-4.4
P/E
CASH FLOW STATEMENT
-37.6 M
OPERATING CASH FLOW
-2.01 M
INVESTING CASH FLOW
21.4 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Pulmonx Corporation
| Net Income | -60.8 M |
| Depreciation & Amortization | 1.55 M |
| Capital Expenditures | -807 K |
| Stock-Based Compensation | 22.1 M |
| Change in Working Capital | -2.56 M |
| Others | 2.12 M |
| Free Cash Flow | -38.4 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (60.8) | (58.9) | (48.7) | (32.2) | (20.7) | (18.5) |
| Depreciation & Amortization | 1.5 | 1.5 | 0.9 | 0.5 | 0.4 | 0.3 |
| Deferred Income Tax | 0 | 49 K | 1.3 | (2.8) | 0.7 | 0.9 |
| Stock Based Compensation | 22.1 | 16.4 | 10.5 | 3.2 | 0.4 | 0.4 |
| Other Operating Activities | 2.1 | 2.8 | 2.5 | 5.5 | 0.9 | 36 K |
| Change in Working Capital | (2.6) | (7.0) | (7.8) | (4.8) | (2.4) | (1.5) |
| Cash From Operations | (37.6) | (45.1) | (41.4) | (30.6) | (20.8) | (18.4) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (0.8) | (1.3) | (3.7) | (0.9) | (0.7) | (0.3) |
| Other Items | (1.2) | (2.9) | (42.6) | 13.6 | (13.5) | 0.5 |
| Cash From Investing Activities | (2.0) | (4.2) | (46.3) | 12.7 | (14.2) | 0.2 |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 1.2 | 27 K | 26 K | 0 | 12 K | 0 |
| Total Debt Repaid | 19.9 | 87 K | 0 | 33.0 | 6.0 | 12.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.5 | 2.5 | 4.5 | 0.4 | 39.6 | 0.1 |
| Cash From Financing Activities | 21.4 | 2.5 | 4.5 | 234.8 | 45.6 | 12.1 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (18.2) | (46.7) | (83.1) | 217.0 | 10.6 | (5.9) |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (38.4) | (46.4) | (45.1) | (31.5) | (21.5) | (18.7) |